Comparison between Platelet Lysate, Platelet Lysate Serum, and Fetal Bovine Serum as Supplements for Cell Culture, Expansion, and Cryopreservation.

cryopreservation culture fetal bovine serum (FBS) fibroblasts human platelet lysate and platelet lysate serum mesenchymal stem cells (MSCs)

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
09 Jan 2024
Historique:
received: 21 11 2023
revised: 23 12 2023
accepted: 02 01 2024
medline: 23 1 2024
pubmed: 23 1 2024
entrez: 23 1 2024
Statut: epublish

Résumé

As cell culture supplements, human platelet lysate (PL) and human platelet lysate serum (PLS) are alternatives to fetal bovine serum (FBS) due to FBS-related issues such as ethical concerns, variability between batches, and the possible introduction of xenogenic contaminants. This study compared the composition and efficacy of PL, PLS, and FBS as supplements in the culture and cryopreservation of human dermal fibroblasts, Wharton's jelly-derived mesenchymal stem cells (WJ-MCS), and adipose tissue (AdMSC). Biochemical components, some growth factors, and cytokines present in each of them were analyzed; in addition, the cells were cultured in media supplemented with 5% PL, 5% PLS, and 10% FBS and exposed to different freezing and thawing solutions with the supplements under study. Biochemical parameters were found to be similar in PL and PLS compared to FBS, with some differences in fibrinogen and calcium concentration. Growth factors and cytokines were higher in PL and PLS compared to FBS. Cell proliferation and morphology showed no significant differences between the three culture media. Regarding the cryopreservation and thawing of cells, better results were obtained with PLS and FBS. In conclusion, PL and PLS are an excellent choice to replace the standard supplement of animal origin (FBS) in the media used for the culture and cryopreservation of fibroblasts, WJ-MSC, and AdMSC.

Identifiants

pubmed: 38255245
pii: biomedicines12010140
doi: 10.3390/biomedicines12010140
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Ministerio de Ciencia, Tecnología e Innovación, Colombia
ID : 642-2018 contract

Auteurs

Juan Manuel Duarte Rojas (JM)

Tissue Engineering and Cellular Therapies Group-GITTC, Faculty of Medicine, University of Antioquia, Medellín 050010, Colombia.
Biomedical Basic Sciences Academic Corporation, University of Antioquia, Medellín 050010, Colombia.

Luz Marina Restrepo Múnera (LM)

Tissue Engineering and Cellular Therapies Group-GITTC, Faculty of Medicine, University of Antioquia, Medellín 050010, Colombia.

Sergio Estrada Mira (S)

Tissue Engineering and Cellular Therapies Group-GITTC, Faculty of Medicine, University of Antioquia, Medellín 050010, Colombia.
Cellular Therapy and Biobank Laboratory, Hospital Alma Mater de Antioquia, University of Antioquia, Medellín 050010, Colombia.

Classifications MeSH